Treatment of Spinal Cord Injury Patients for Neurogenic Bladder: Anticholinergic Agent vs. Mirabegron

EARLY_PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 5, 2018

Primary Completion Date

March 23, 2020

Study Completion Date

March 31, 2021

Conditions

Spinal Cord InjuriesNeurogenic BladderCognitive Change

Interventions

DRUG

Mirabegron

Beta-3 adenoreceptor agonist

Trial Locations (1)

South Texas Veterans Health Care System, Audie L. Murphy Hospital, San Antonio

All Listed Sponsors

lead

The University of Texas Health Science Center at San Antonio

OTHER

NCT03612401 - Treatment of Spinal Cord Injury Patients for Neurogenic Bladder: Anticholinergic Agent vs. Mirabegron | Biotech Hunter | Biotech Hunter